COMMUNIQUÉS West-GlobeNewswire

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
30/04/2025
FOSTER CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
30/04/2025
SUNNYVALE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Codexis to Report First Quarter 2025 Financial Results on May 14
30/04/2025
REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report [...]
RxSight, Inc. to Present at the Bank of America Healthcare Conference
30/04/2025
ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery [...]
Vaxart to Present at the Citizens Life Sciences Conference
30/04/2025
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that members of the management team will present at the Citizens Life Sciences conference taking place May 7-8 [...]
Iridex to Report First Quarter 2025 Financial Results on May 13, 2025
30/04/2025
MOUNTAIN VIEW, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for [...]
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
30/04/2025
CEA-targeted ISAC elicits complete responses in mice and is well-tolerated in NHPs PD-L1 ISAC directly activates and reprograms PD-L1-expressing myeloid cells in the TME to drive complete responses and immunological [...]
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
30/04/2025
Conference call begins at 4:30 p.m. Eastern time today MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, [...]
Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits
30/04/2025
Acquisition Broadens Access to Virtual Mental Health Services with In-Network Health Plan Relationships Representing More Than 100 Million Covered Lives PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health ( [...]
MIMEDX Announces First Quarter 2025 Operating and Financial Results
30/04/2025
Net Sales of $88 million Grew 4% Year-Over-Year for the First Quarter First Quarter GAAP Net Income and Earnings Per Share were $7 Million and $0.05 , Respectively First Quarter Adjusted EBITDA was $17 Million, or 20% [...]
Burn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meeting
30/04/2025
DALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView ® System, which uses multi-spectral imaging and AI algorithms [...]
Cytokinetics to Participate in May Investor Conferences
30/04/2025
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in the following investor conferences in May: The [...]
Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025
30/04/2025
Article R. 22-10-23 of the French Commercial Code Market: Euronext Paris ISIN code / Mnemo: FR0013233012 / IVA Web site: www.inventivapharma.com Date Number of shares outstanding Total voting rights, gross (1) Total [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 11 avril 2025
30/04/2025
Article R. 22-10-23 du Code de commerce Place de cotation : Euronext Paris Code ISIN / Mnémo : FR0013233012 / IVA Site web : www.inventivapharma.com Date Nombre de titres composant le capital en circulation Nombre total [...]
Combined General Meeting of May 22, 2025 - Availability of the preparatory documents
30/04/2025
Daix (France), New York City (New York, United States), April 30, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies [...]
Assemblée Générale Mixte du 22 mai 2025 - Modalités de mise à disposition des documents préparatoires
30/04/2025
Daix (France), New York City (New York, Etats-Unis), le 30 avril 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique [...]
DBV Technologies Reports First Quarter 2025 Financial Results
30/04/2025
Châtillon, France, April 30, 2025 DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage [...]
DBV Technologies publie ses résultats financiers du 1er trimestre 2025
30/04/2025
Châtillon, France, le 30 avril (22 :00 CEST) 2025 DBV Technologies publie ses résultats financiers du 1er trimestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : [...]
Mdxhealth to Release First Quarter 2025 Financial Results on May 14
30/04/2025
Company to Host Conference Call with Live Q&A, May 14, 2025, at 4:30pm ET / 22:30 CET IRVINE, California – April 30, 2025 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, [...]

Pages